PMID- 21697547 OWN - NLM STAT- MEDLINE DCOM- 20111109 LR - 20131121 IS - 1945-1997 (Electronic) IS - 0098-6151 (Linking) VI - 111 IP - 5 Suppl 4 DP - 2011 May TI - Type 2 diabetes mellitus: practical approaches for primary care physicians. PG - S3-12; quiz S13 AB - The incidence and prevalence of type 2 diabetes mellitus (T2DM) have reached epidemic proportions in the United States. In addition to growing numbers of individuals in whom T2DM has been diagnosed, in numerous others T2DM or prediabetes remains undiagnosed or is likely to develop in the near future. Identification of individuals at risk for T2DM, as well as those who may already have the disease but in whom it has not yet been diagnosed, is a key element in reducing the overall burden of this disease. Early initiation of treatment can prevent or delay disease progression and reduce the risk for diabetes-related complications. Achieving evidence-based clinical goals by implementing effective management strategies substantially reduces the risk of morbidity and mortality and ultimately improves patient outcomes. A review of the latest and most effective approaches to T2DM management and practical suggestions for implementing treatment strategies in order to provide optimal T2DM care will be presented. FAU - Gavin, James R 3rd AU - Gavin JR 3rd AD - Healing Our Village, Inc, 10104 Senate Dr, Suite 210, Lanham, MD 20706-4393, USA. drgavin@healingourvillage.com FAU - Freeman, Jeffrey S AU - Freeman JS FAU - Shubrook, Jay H Jr AU - Shubrook JH Jr FAU - Lavernia, Frank AU - Lavernia F LA - eng PT - Journal Article PT - Review PL - United States TA - J Am Osteopath Assoc JT - The Journal of the American Osteopathic Association JID - 7503065 RN - 0 (Hypoglycemic Agents) RN - 0 (Incretins) RN - 9100L32L2N (Metformin) SB - IM MH - Diabetes Mellitus, Type 2/diagnosis/*drug therapy/epidemiology MH - Disease Progression MH - Health Knowledge, Attitudes, Practice MH - Humans MH - Hypoglycemic Agents/*therapeutic use MH - Incretins/therapeutic use MH - Life Style MH - Mass Screening MH - Metformin/therapeutic use MH - *Physicians, Primary Care MH - Risk Assessment MH - Risk Factors EDAT- 2011/07/01 06:00 MHDA- 2011/11/10 06:00 CRDT- 2011/06/24 06:00 PHST- 2011/06/24 06:00 [entrez] PHST- 2011/07/01 06:00 [pubmed] PHST- 2011/11/10 06:00 [medline] AID - 111/5_suppl_4/S3 [pii] PST - ppublish SO - J Am Osteopath Assoc. 2011 May;111(5 Suppl 4):S3-12; quiz S13.